SUBSCRIBE
SUBSCRIBE
News   Policy

Merck & Co., Inc. (JOBS) Loses Effort to Dismiss 24 Fosamax Cases

September 10, 2009 | 
1 min read

Bookmark and Share

Reuters -- A Manhattan federal judge has rejected Merck & Co’s effort to dismiss 24 cases alleging that its Fosamax drug treatment for osteoporosis causes jaw damage.

Legal
Merck & Co.
MORE ON THIS TOPIC
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: AstraZeneca building in Gothenburg/iStoc
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
December 5, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
AstraZeneca, Merus Notch Cancer Approvals
December 5, 2024
 · 
212 min read
 · 
BioSpace Editorial Staff
Novartis' office building in Marburg, Germany
Legal
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac